Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2002
11/14/2002US20020169143 Methods and products related to low molecular weight heparin
11/14/2002US20020169137 Preventing or inhibiting pathological beta-amyloid plaque formation in conditions such as Alzheimer's disease
11/14/2002US20020169118 TNF receptors, TNF binding proteins and DNAs coding for them
11/14/2002US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002US20020169106 Administering an OB-cadherin CAR (cell adhesion recognition) sequence
11/14/2002US20020169104 Novel ectoparasite saliva proteins and apparatus to collect such proteins
11/14/2002US20020168779 Apparatus for use in the generation and storage of libraries of human cells
11/14/2002US20020168769 Nucleotide sequences for use tools in generating genetic engineered plants
11/14/2002US20020168766 Generating genetically engineered pluripotent stem cells for use in gene therapy; obtain cells transform with preferential expression vector, recover genetically engineered cells
11/14/2002US20020168765 Early stage multipotential stem cells in colonies of bone marrow stromal cells
11/14/2002US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002US20020168757 Test device and method of making same
11/14/2002US20020168755 Mammalian TNF-alpha convertases
11/14/2002US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002US20020168748 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections
11/14/2002US20020168745 Transacylases of the paclitaxel biosynthetic pathway
11/14/2002US20020168743 Polypeptide for use in as tool in monitoring microbial propagation in high throughput assays
11/14/2002US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002US20020168735 Protein for use in the prevention of fungal infection
11/14/2002US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002US20020168703 Process for the manufacture of carotenoids and biologically useful materials thereof
11/14/2002US20020168700 Measuring Factor VIIa activity in sample; obtain sample, incubate with buffer and substrate, measure amount of catalyzed substrate, catalyzed substrate indicates factor VIIA activity
11/14/2002US20020168697 Antimicrobial methods and materials
11/14/2002US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002US20020168693 Kit for use in the detection of modulators of ligase activity
11/14/2002US20020168691 Methods and kits useful for the simplification of complex peptide mixtures
11/14/2002US20020168690 Peptide for use in the treatment of arthritis
11/14/2002US20020168686 Evaluating activity of proteins; obtain protein, incubate with modulators, generate activity spectrum, classify protein
11/14/2002US20020168678 Separation of preferential nucleotide sequences in sample; obtain sample, incubate with cleavage enzyme, apply electric current, separate nucleotide squences, evaluate nucleotide sequence pattern
11/14/2002US20020168677 Fluidic waveguide for use in detection of preferential particles in sample
11/14/2002US20020168676 Method of synthesizing nucleic acid
11/14/2002US20020168675 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
11/14/2002US20020168674 Amplifying and isolating preferential nucleotide sequences; obtain preferential nucleotide sequence library, incubate with primers, amplify nucleotide sequences, digest, recover preferential nucleotide sequences
11/14/2002US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002US20020168671 Chip-based isothermal amplification devices and methods
11/14/2002US20020168670 Identification of disease predictive nucleic acids
11/14/2002US20020168669 Patterned polymer synthesis
11/14/2002US20020168666 Hybridization probe and target nucleic acid detecting kit, target nucleic acid detecting apparatus and target nucleic acid detecting method using the same
11/14/2002US20020168663 Generating solid support for analyzing preferential particles; obtain chemical intermediates for generating solid support, generate solid support, join probe to solid support, determine concentration of probe bound to solid support
11/14/2002US20020168662 Sperm protein 17 for the diagnosis and treatment of cancer
11/14/2002US20020168661 DNA for evaluating the progression potential of cervical lesions
11/14/2002US20020168658 Amplification of nucleic acids
11/14/2002US20020168657 Rare event detection system
11/14/2002US20020168656 Diagnosing nervous system disorder; obtain tissue sample, extract nucleotide sequences, detect nucleotide sequence polymorphism, presence of polymorphism indicates nervous system disorder
11/14/2002US20020168654 Method and system for modeling cellular metabolism
11/14/2002US20020168650 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/14/2002US20020168649 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement
11/14/2002US20020168648 Detecionand determinationof preferential nucleotide sequences; generate microarrays, incubate with preferential nucleotide sequence, expose to probe, measure fluorescent intensity of sample, compare to control, determine nucleotide sequence
11/14/2002US20020168646 Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
11/14/2002US20020168645 Analysis of polynucleotide sequence
11/14/2002US20020168644 Labeling biopolymers; obtain sample of biopolymer, incubate with solid support, remove preerential functional groups, detect signal and evaluate sample
11/14/2002US20020168643 Devices and methods for simultaneous separation and purification of molecular samples
11/14/2002US20020168642 Sequencing duplex DNA by mass spectroscopy
11/14/2002US20020168641 Detecting preferential nucleotide sequences in sample; obtain label, incubate and join to nucleotide sequences, detect signal from nucleotide sequences
11/14/2002US20020168639 Microarays for use in human therapeutics and diagnostics
11/14/2002US20020168637 Polypeptide
11/14/2002US20020168636 Intensifying response of bacteria to chemical intermediates; obtain bacteria, transform with vector expressing activator protein, express vector, incubate with intermediate, monitor and evaluate activity of bacteria
11/14/2002US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002US20020168634 Detecting genes associated with cell propagation; generate library of preferential cell, incubate with grid, mutagenize, propagate, harvest, extract and isolate nucleotide sequences, incubate with probes, detect pattern, compare to control
11/14/2002US20020168633 Nucleotide fragment of the 23s rna of the genus chlamydia, use as a probe, primer, and in a reagent and a detection procedure
11/14/2002US20020168632 Detecting defects by monitoring bodily fluids; obtain bodily fluid, incubate with particles, monitor sample for preferential proteins, evaluate for preferential defects
11/14/2002US20020168630 Detecting viable cells in sample; obtain cells, incubate with fluorescent dyes, detect fluorescence, compare to control
11/14/2002US20020168628 Variant of LAV viruses
11/14/2002US20020168626 Using probes for the detection of preferential viral nucleotide sequences in sample; obtain nucleotide sequences, incubate with probes, detect viral nucleotide sequences
11/14/2002US20020168625 Detecting and measuring the activity of transport proteins; obtain cells, incubate with membrane protein, expose to buffers, detect and measure signal from sample
11/14/2002US20020168623 Compositions and methods for induction of proteins involved in xenobiotic metabolism
11/14/2002US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002US20020168373 House dust mite allergen, Der f VII, and uses therefor
11/14/2002US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002US20020168347 Monocyte derived cells, in a purified form, presenting antigenic epitopes on their membranes after interioriztion and processing of an antigen-antibody complex, such epitope corresponding to proteolytic degradation product of antigen
11/14/2002US20020168345 Methods of monitoring HIV drug resistance using adenoviral vectors
11/14/2002US20020168094 System, method, and computer software product for gain adjustment in biological microarray scanner
11/14/2002US20020166764 Electrochemical immunoassay for detecting an analyte in a sample
11/14/2002DE10112515A1 Detecting methylation status of test DNA in a mixture, useful for diagnosis and prognosis of disease, comprises bisulfite treatment then selective amplification of test DNA
11/14/2002CA2458207A1 Determination of a genetic predisposition for behavioural disorders
11/14/2002CA2452844A1 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002CA2447470A1 Peptide deformylase activated prodrugs
11/14/2002CA2447386A1 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002CA2447360A1 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002CA2446838A1 Novel mutation
11/14/2002CA2446825A1 Methods for determining the prognosis for cancer patients using tucan
11/14/2002CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002CA2446666A1 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002CA2446626A1 Methods for the reduction of stutter in microsatellite amplification
11/14/2002CA2446531A1 Design of artificial genes for use as controls in gene expression analysis systems
11/14/2002CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002CA2446443A1 Methods for the reduction of stutter in microsatellite amplification using sorbitol
11/14/2002CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002CA2446322A1 Anti-microbial peptides and compositions
11/14/2002CA2446262A1 Method and apparatus for high-speed approximate sub-string searches
11/14/2002CA2446236A1 Method of performing an assay, apparatus therefor, and a method of manufacturing and apparatus
11/14/2002CA2446207A1 A high throughput assay for identification of gene expression modifiers
11/14/2002CA2446206A1 A molecular tag code for monitoring a product and process using same